Treatment preferences for epidermal growth factor receptor mutation-positive non-small cell lung cancer with brain metastasis: a large-scale survey from Chinese oncologists

BACKGROUND: Radiotherapy combined with tyrosine kinase inhibitor (TKI) has drawn extensive attention as a treatment regimen for patients with epithelial growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) with brain metastases (BMs). However, the optimal regimens and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yongfeng, Qian, Jie, Shen, Lan, Ji, Wenxiang, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848395/
https://www.ncbi.nlm.nih.gov/pubmed/35282104
http://dx.doi.org/10.21037/atm-21-6413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848395/
https://www.ncbi.nlm.nih.gov/pubmed/35282104
http://dx.doi.org/10.21037/atm-21-6413

Ejemplares similares